Atossa Therapeutics Inc.

10/31/2024 | Press release | Distributed by Public on 10/31/2024 06:17

Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z) Endoxifen’s Potential to Rapidly Reduce Ki 67 and Tumor Volume in ER+/HER2 Breast Cancer

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.